To mark Ophthalmology Times' 50th anniversary, we invited top experts to reflect on the most significant innovations in ...

PulseSight Technologies recently announced the successful dosing of the first patient in the phase I clinical trial ...

Alcon's Clareon Panoptix Pro IOL enhances cataract surgery with advanced light utilization and low visual disturbance.

The trial will evaluate the safety and tolerability of Tinlarebant and its potential to reduce atrophic lesion growth rate in ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...